| Patient | Satchel Paige |
|---|---|
| Date of birth | 1906-07-07 |
| Identifiers | MRN HR-ML047-SYN-TD; SSN (made up) 000-47-3381 |
| Document date | 2026-11-01 |
| Author | Delphine Whitaker-Osei, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Establishing primary care for two years of breathlessness on exertion and a morning cough: history, examination, blood tests including alpha-1 antitrypsin and eosinophils, ECG, NT-proBNP, cardiovascular risk, vaccines, a reliever inhaler and a pulmonology consultation. Concerns: Breathless on stairs and on walks he used to take easily; He wants straight answers and his own numbers, and to be treated the same as anyone else; He wants to keep fishing and speaking to young people. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Albuterol 90 micrograms per inhalation metered-dose inhaler with a spacer, two inhalations every four hours as needed for breathlessness | Two inhalations with a spacer every 4 hours as needed | Respiratory tract route | 1979-07-14 | active | S |
| Umeclidinium 62.5 micrograms with vilanterol 25 micrograms dry powder inhaler (a LAMA with a LABA), one inhalation once a day | One inhalation each morning; a strong, deep breath in | Respiratory tract route | 1979-07-28 | active | S |
| Atorvastatin 20 mg tablet once a day | One tablet each evening | Oral route | 1979-07-14 | active | S |
| Prednisone 40 mg (two 20 mg tablets) by mouth each morning for five days | Two tablets each morning with food for five days | Oral route | 1979-09-22 to 1979-09-26 | completed | S |
| Doxycycline 100 mg capsule by mouth twice a day for five days | One capsule twice a day with a full glass of water, sitting up, for five days | Oral route | 1979-09-22 to 1979-09-26 | completed | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| 12-lead ECG: sinus rhythm at 82; normal axis; no Q waves, ST changes or signs of right ventricular strain; P waves normal | 1979-07-14 to 1979-07-14 | completed | S |
| Spirometry before and after 400 micrograms of albuterol, meeting ATS/ERS acceptability and repeatability standards, interpreted with the GLI Global race-neutral reference equations: post-bronchodilator FEV1 2.02 L (61% predicted), FVC 3.48 L, FEV1/FVC 0.58; a 0.10 L (5%) bronchodilator response | 1979-07-28 to 1979-07-28 | completed | S |
| Low-dose CT of the chest for lung cancer screening: centrilobular emphysema, worst in the upper lobes; a 4 mm solid nodule in the right lower lobe (Lung-RADS 2, benign appearance); moderate coronary artery calcification; no mass or enlarged nodes | 1979-08-04 to 1979-08-04 | completed | S |
| Outpatient pulmonary rehabilitation, twice a week for ten weeks (20 sessions): endurance and strength training, breathing techniques and education | 1979-08-11 to 1979-10-22 | completed | S |
| Chest X-ray, posteroanterior and lateral: hyperinflated lungs with flattened diaphragms; no consolidation, effusion, pneumothorax or enlarged heart | 1979-09-22 to 1979-09-22 | completed | S |
| Advance care planning conversation, about 25 minutes, with his consent | 1979-10-06 to 1979-10-06 | completed | S |
| Ultrasound of the abdominal aorta for aneurysm screening: maximum diameter 2.4 cm; no aneurysm | 1979-10-20 to 1979-10-20 | completed | S |
| 12-lead ECG after the exacerbation: sinus rhythm at 76; unchanged from intake; no ischemic changes, arrhythmia or right heart strain | 1979-10-27 to 1979-10-27 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1979-07-14 | Pneumococcal conjugate vaccine PCV20, single dose | completed | S |
| 1979-07-14 | Tdap, booster | completed | S |
| 1979-10-06 | Influenza vaccine, high-dose, this season | completed | S |
| 1979-10-06 | Respiratory syncytial virus vaccine, single dose | completed | S |
| 1979-10-06 | COVID-19 mRNA vaccine, this season's formula | completed | S |
| 1979-10-06 | Recombinant zoster vaccine, dose 1 of 2 | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1938 | Arm trouble from the late 1930s, with an arm injury in 1938; recovered the next year | D (CLM-0005) |
| In his later years (date not recorded) | Emphysema and heart trouble in his later years; onset, diagnosis and treatment not recorded | D (CLM-0009) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Concern | Status | Evidence |
|---|---|---|
| Breathless on stairs and on walks he used to take easily | active | S |
| He wants straight answers and his own numbers, and to be treated the same as anyone else | active | S |
| He wants to keep fishing and speaking to young people | active | S |
Most recent measures: Hemoglobin [Mass/volume] in Blood 15.2 on 1979-07-14; Leukocytes [#/volume] in Blood by Automated count 7.1 on 1979-07-14; Eosinophils [#/volume] in Blood by Automated count 0.08 on 1979-07-14; Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma 142 on 1979-07-14; Sodium [Moles/volume] in Serum or Plasma 140 on 1979-07-14; Potassium [Moles/volume] in Serum or Plasma 4.3 on 1979-07-14; Creatinine [Mass/volume] in Serum or Plasma 1.08 on 1979-07-14; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1974)/1.73 sq M 71 on 1979-07-14; Glucose [Mass/volume] in Serum or Plasma 96 on 1979-07-14; Hemoglobin A1c/Hemoglobin.total in Blood 5.6 on 1979-07-14; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 21 on 1979-07-14; Cholesterol [Mass/volume] in Serum or Plasma 158 on 1979-09-08; Cholesterol in HDL [Mass/volume] in Serum or Plasma 46 on 1979-09-08; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 86 on 1979-09-08; Triglyceride [Mass/volume] in Serum or Plasma 130 on 1979-09-08; Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma 92 on 1979-07-14; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 on 1979-10-27; Total score [AUDIT-C] 1 on 1979-07-14; FEV1 --pre bronchodilation 1.92 on 1979-07-28; FEV1 --post bronchodilation 2.02 on 1979-07-28; Forced vital capacity [Volume] Respiratory system --post bronchodilation 3.48 on 1979-07-28; FEV1/FVC --post bronchodilation 0.58 on 1979-07-28; FEV1 measured/predicted 61 on 1979-07-28; pH of Arterial blood 7.42 on 1979-07-28; Carbon dioxide [Partial pressure] in Arterial blood 40 on 1979-07-28; Oxygen [Partial pressure] in Arterial blood 70 on 1979-07-28; Six minute walk test 425 on 1979-10-27; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1979-10-06; Total score [Mini-Cog] 5 on 1979-10-06 [S]
Strengths and supports: engagement in care [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Breathlessness on exertion for about two years, now after one flight of stairs or a block on the level (mMRC 2), with a morning cough and a little clear sputum most days; no chest pain, ankle swelling, orthopnea, wheeze at rest or weight loss; a former smoker of about 30 pack-years; cause under evaluation with spirometry and a pulmonology consultation | resolved | confirmed | R06.09 | S — Synthetic presenting problem anchored to his documented emphysema; superseded when spirometry at the consultation confirmed COPD. |
| Chronic obstructive pulmonary disease, GOLD grade 2 (post-bronchodilator FEV1/FVC 0.58, FEV1 61% predicted by the race-neutral GLI Global equations), GOLD group B (CAT 18, mMRC 2, no exacerbation in the past year); alpha-1 antitrypsin normal; blood eosinophils 0.08 x 10^3/uL; synthetic modern diagnosis linked to his documented emphysema | active | confirmed | J44.9 | S — Synthetic modern diagnosis made at the consultation, anchored to his documented emphysema; its onset and course in the modern episode are synthetic. |
| Former cigarette smoker, about 30 pack-years, stopped eleven years ago on his own; no use since | active | confirmed | Z87.891 | S — Synthetic smoking history: whether he smoked is not documented in the sources read, so the history is synthetic and labeled as such. |
| Hyperlipidemia: LDL 148 mg/dL, HDL 44 and triglycerides 160 at intake; estimated 10-year cardiovascular risk about 18 percent; atorvastatin started by shared decision | active | confirmed | E78.5 | S — Synthetic cardiovascular risk factor anchored to his documented heart trouble; not a claim about his real lipids. |
| Moderate exacerbation of COPD with a viral cold: more breathlessness, more sputum turning green, and wheeze for three days; oxygen saturation 92 percent; no pneumonia on chest X-ray; treated at home with prednisone and doxycycline; recovered | resolved | confirmed | J44.1 | S — Synthetic exacerbation at the sick visit; not a historical claim. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1979-07-14 | Hemoglobin [Mass/volume] in Blood | 15.2 | g/dL | 13.2-17.1 g/dL | Normal | S |
| 1979-07-14 | Leukocytes [#/volume] in Blood by Automated count | 7.1 | 10*3/uL | 3.8-10.8 10*3/uL | Normal | S |
| 1979-07-14 | Eosinophils [#/volume] in Blood by Automated count | 0.08 | 10*3/uL | For COPD treatment decisions: below 0.10 argues against an inhaled corticosteroid; 0.30 or more favors one | Normal | S |
| 1979-07-14 | Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma | 142 | mg/dL | 90-200 mg/dL | Normal | S |
| 1979-07-14 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-146 mmol/L | Normal | S |
| 1979-07-14 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.3 mmol/L | Normal | S |
| 1979-07-14 | Creatinine [Mass/volume] in Serum or Plasma | 1.08 | mg/dL | 0.7-1.3 mg/dL | Normal | S |
| 1979-07-14 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1974)/1.73 sq M | 71 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1979-07-14 | Glucose [Mass/volume] in Serum or Plasma | 96 | mg/dL | 65-99 mg/dL | Normal | S |
| 1979-07-14 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.6 | % | <=5.6% | Normal | S |
| 1979-07-14 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 21 | U/L | 9-46 U/L | Normal | S |
| 1979-07-14 | Cholesterol [Mass/volume] in Serum or Plasma | 224 | mg/dL | <=199 mg/dL | High | S |
| 1979-07-14 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 44 | mg/dL | >=40 mg/dL | Normal | S |
| 1979-07-14 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 148 | mg/dL | <=99 mg/dL | High | S |
| 1979-07-14 | Triglyceride [Mass/volume] in Serum or Plasma | 160 | mg/dL | <=149 mg/dL | High | S |
| 1979-07-14 | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma | 92 | pg/mL | Below 125 pg/mL makes heart failure unlikely in an outpatient | Normal | S |
| 1979-07-14 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | {score} | S | ||
| 1979-07-14 | Total score [AUDIT-C] | 1 | {score} | S | ||
| 1979-07-28 | FEV1 --pre bronchodilation | 1.92 | L | Lower limit of normal, GLI Global (race-neutral) for age, sex and height | Low | S |
| 1979-07-28 | FEV1 --post bronchodilation | 2.02 | L | Lower limit of normal, GLI Global (race-neutral) | Low | S |
| 1979-07-28 | Forced vital capacity [Volume] Respiratory system --post bronchodilation | 3.48 | L | Lower limit of normal, GLI Global (race-neutral) | Normal | S |
| 1979-07-28 | FEV1/FVC --post bronchodilation | 0.58 | {ratio} | GOLD fixed ratio 0.70; post-bronchodilator ratio below 0.70 confirms airflow obstruction (GLI Global lower limit of normal about 0.62) | Low | S |
| 1979-07-28 | FEV1 measured/predicted | 61 | % | GOLD grade 1 at 80% or more, grade 2 at 50 to 79% | Low | S |
| 1979-07-28 | pH of Arterial blood | 7.42 | [pH] | 7.35-7.45 [pH] | Normal | S |
| 1979-07-28 | Carbon dioxide [Partial pressure] in Arterial blood | 40 | mm[Hg] | 35-45 mmHg | Normal | S |
| 1979-07-28 | Oxygen [Partial pressure] in Arterial blood | 70 | mm[Hg] | Long-term oxygen threshold: 55 mm Hg or less (60 or less with cor pulmonale or polycythemia) | Low | S |
| 1979-07-28 | Six minute walk test | 360 | m | Predicted about 520 m for his age, sex and height; lower limit about 400 m | Low | S |
| 1979-09-08 | Cholesterol [Mass/volume] in Serum or Plasma | 158 | mg/dL | <=199 mg/dL | Normal | S |
| 1979-09-08 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 46 | mg/dL | >=40 mg/dL | Normal | S |
| 1979-09-08 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 86 | mg/dL | <=99 mg/dL | Normal | S |
| 1979-09-08 | Triglyceride [Mass/volume] in Serum or Plasma | 130 | mg/dL | <=149 mg/dL | Normal | S |
| 1979-10-06 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 1979-10-06 | Total score [Mini-Cog] | 5 | {score} | S | ||
| 1979-10-27 | Six minute walk test | 425 | m | Predicted about 520 m for his age, sex and height; lower limit about 400 m | Normal | S |
| 1979-10-27 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 2 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1979-07-14 | Body height | 191 | cm | S |
| 1979-07-14 | Body weight | 82.6 | kg | S |
| 1979-07-14 | Body mass index (BMI) [Ratio] | 22.6 | kg/m2 | S |
| 1979-07-14 | Systolic blood pressure | 136 | mm[Hg] | S |
| 1979-07-14 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 1979-07-14 | Heart rate | 84 | /min | S |
| 1979-07-14 | Respiratory rate | 18 | /min | S |
| 1979-07-14 | Body temperature | 36.7 | Cel | S |
| 1979-07-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 94 | % | S |
| 1979-07-28 | Body height | 191 | cm | S |
| 1979-07-28 | Body weight | 82.4 | kg | S |
| 1979-07-28 | Body mass index (BMI) [Ratio] | 22.6 | kg/m2 | S |
| 1979-07-28 | Systolic blood pressure | 132 | mm[Hg] | S |
| 1979-07-28 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 1979-07-28 | Heart rate | 82 | /min | S |
| 1979-07-28 | Respiratory rate | 18 | /min | S |
| 1979-07-28 | Body temperature | 36.6 | Cel | S |
| 1979-07-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 94 | % | S |
| 1979-09-08 | Body height | 191 | cm | S |
| 1979-09-08 | Body weight | 82.8 | kg | S |
| 1979-09-08 | Body mass index (BMI) [Ratio] | 22.7 | kg/m2 | S |
| 1979-09-08 | Systolic blood pressure | 130 | mm[Hg] | S |
| 1979-09-08 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1979-09-08 | Heart rate | 78 | /min | S |
| 1979-09-08 | Respiratory rate | 16 | /min | S |
| 1979-09-08 | Body temperature | 36.6 | Cel | S |
| 1979-09-08 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 | % | S |
| 1979-10-27 | Body height | 191 | cm | S |
| 1979-10-27 | Body weight | 83.4 | kg | S |
| 1979-10-27 | Body mass index (BMI) [Ratio] | 22.9 | kg/m2 | S |
| 1979-10-27 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1979-10-27 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1979-10-27 | Heart rate | 76 | /min | S |
| 1979-10-27 | Respiratory rate | 16 | /min | S |
| 1979-10-27 | Body temperature | 36.6 | Cel | S |
| 1979-10-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 | % | S |
| 1979-10-06 | Body height | 191 | cm | S |
| 1979-10-06 | Body weight | 83 | kg | S |
| 1979-10-06 | Body mass index (BMI) [Ratio] | 22.8 | kg/m2 | S |
| 1979-10-06 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1979-10-06 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1979-10-06 | Heart rate | 76 | /min | S |
| 1979-10-06 | Respiratory rate | 16 | /min | S |
| 1979-10-06 | Body temperature | 36.6 | Cel | S |
| 1979-10-06 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 | % | S |
| 1979-09-22 | Body height | 191 | cm | S |
| 1979-09-22 | Body weight | 82.2 | kg | S |
| 1979-09-22 | Body mass index (BMI) [Ratio] | 22.5 | kg/m2 | S |
| 1979-09-22 | Systolic blood pressure | 134 | mm[Hg] | S |
| 1979-09-22 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 1979-09-22 | Heart rate | 96 | /min | S |
| 1979-09-22 | Respiratory rate | 22 | /min | S |
| 1979-09-22 | Body temperature | 37.5 | Cel | S |
| 1979-09-22 | Oxygen saturation in Arterial blood by Pulse oximetry | 92 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1979-07-14 | Establishing primary care for two years of breathlessness on exertion and a morning cough: history, examination, blood tests including alpha-1 antitrypsin and eosinophils, ECG, NT-proBNP, cardiovascular risk, vaccines, a reliever inhaler and a pulmonology consultation | finished | S |
| 1979-07-28 | Two-week review on the day of the pulmonology consultation: spirometry with race-neutral interpretation, blood gas, six-minute walk, GOLD group and first maintenance inhaler, inhaler technique, pulmonary rehabilitation and lung cancer screening | finished | S |
| 1979-09-08 | Eight-week review: symptoms on the new inhaler, technique, rehabilitation, the screening CT and the lipid response | finished | S |
| 1979-10-27 | Fifteen-week review after an exacerbation and pulmonary rehabilitation: symptoms, exacerbation history, GOLD group, oxygen, the action plan and the plan ahead | finished | S |
| 1979-09-22 | Same-day sick visit for a COPD exacerbation | finished | S |
| 1979-10-06 | Subsequent annual wellness visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Breathlessness work-up at intake: symptoms with the CAT and mMRC, exacerbation history over the past year, smoking history and examination; blood count with eosinophils, alpha-1 antitrypsin once, kidney function, HbA1c, lipids, NT-proBNP and a 12-lead ECG; resting oxygen saturation read with care in darker skin | completed | GL-GOLD-2025, GL-CMID-2026, GL-ATS-RACE-2023 | S |
| Pulmonology consultation to confirm the diagnosis with spirometry, interpret it with race-neutral equations, and advise on treatment, oxygen and rehabilitation | completed | GL-GOLD-2025, GL-ATS-RACE-2023 | S |
| Albuterol with a spacer as needed for breathlessness, with technique checked at the visit | completed | GL-GOLD-2025 | S |
| Maintenance therapy for GOLD group B: a LAMA with a LABA (umeclidinium with vilanterol) once daily; no inhaled corticosteroid with eosinophils below 0.10 x 10^3/uL and no exacerbations; inhaler technique and inspiratory effort checked at every visit; treatment reviewed at each follow-up for symptoms and exacerbations | completed | GL-GOLD-2025, GL-CMID-2026 | S |
| Pulmonary rehabilitation: twice a week for about ten weeks, with six-minute walks at entry and exit, then a home exercise program | completed | GL-ATS-PR-2023, GL-CMID-2026 | S |
| Oxygen: room-air arterial blood gas and six-minute walk oximetry; long-term oxygen only if resting PaO2 is 55 mm Hg or less (60 with cor pulmonale or polycythemia), confirmed twice; no long-term or ambulatory oxygen for moderate desaturation | completed | GL-ATS-LTOT-2020, GL-LOTT-2016, GL-SJODING-2020 | S |
| Lung cancer screening: yearly low-dose CT at 50 to 80 with 20 or more pack-years, after shared decision-making, while he has quit within fifteen years and remains fit for treatment | completed | GL-USPSTF-LUNG-2021, GL-CMID-2026 | S |
| Cardiovascular risk: moderate-intensity atorvastatin by shared decision, with a lipid panel at about eight weeks; blood pressure at each visit; ECG reviewed after any exacerbation | completed | GL-USPSTF-STATIN-2022, GL-GOLD-2025 | S |
| Vaccines: PCV20 and Tdap now; influenza, RSV and COVID-19 in the autumn; recombinant zoster | completed | GL-CDC-IMZ-2026, GL-GOLD-2025 | S |
| COPD action plan, spoken and written: what to do on a good day, when symptoms worsen (reliever, call the clinic the same day), and when to call 911; staying smoke-free | completed | GL-GOLD-2025 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Find the cause of the breathlessness | 1979-07-28 | completed | COPD confirmed by spirometry (post-bronchodilator FEV1/FVC 0.58); heart failure unlikely (NT-proBNP 92, normal ECG); alpha-1 antitrypsin normal | S |
| Walk farther with less breathlessness | 1979-10-27 | completed | Six-minute walk 360 to 425 m after rehabilitation; CAT 18 to 11 | S |
| Fewer and milder flare-ups, treated early | 1980-07-14 | active | One moderate exacerbation treated at home within a day of starting, using the action plan; no hospital stay | S |
| LDL below 100 mg/dL | 1979-09-08 | completed | LDL 148 to 86 mg/dL on atorvastatin 20 mg | S |
| Vaccines up to date | 1979-10-06 | completed | PCV20 and Tdap at intake; influenza, RSV, COVID-19 and the first zoster dose at the wellness visit | S |